TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Bio-Gene Technology Ltd. ( (AU:BGT) ).
Bio-Gene Technology Limited has received a $519,500 research and development tax incentive from the Australian Taxation Office, reflecting its significant R&D expenditure in the 2025 financial year. This incentive supports the development of Bio-Gene’s innovative insecticides, Flavocide® and Qcide®, which are designed to target insects with a new mode of action, enhancing the company’s position in global markets and addressing the challenges of insecticide resistance.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited is an Australian company focused on developing novel bio-insecticides to combat global insecticide resistance. Their products, based on naturally occurring compounds, aim to control pests with minimal impact on human health and the environment. Bio-Gene’s offerings have applications in crop protection, grain storage, public health, and consumer uses, providing effective and safe pest management solutions.
Average Trading Volume: 724,646
Technical Sentiment Signal: Hold
Current Market Cap: A$8.54M
See more insights into BGT stock on TipRanks’ Stock Analysis page.